Previous studies have shown that CXCR4 promotes tumor cell proliferation and migration, mostly through its downstream ERK1/2 and AKT pathways [33, 34], and therefore, we examined whether the dysregulation of KDM6B expression affects the ERK and AKT pathways in GC cells. Here, CXCR4 is linked to gastric cancer.